Free Trial

MIRA Pharmaceuticals (MIRA) Insider Trading & Ownership

MIRA Pharmaceuticals logo
$1.06 +0.06 (+6.00%)
(As of 12/20/2024 05:31 PM ET)

MIRA Pharmaceuticals (NASDAQ:MIRA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.65%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$8,178.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$77,019.90
Get MIRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling MIRA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MIRA Insider Buying and Selling by Quarter

MIRA Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/19/2024Erez AminovCEOSell55,410$1.39$77,019.90  
5/21/2024Erez AminovCEOBuy8,700$0.94$8,178.00  
(Data available from 1/1/2013 forward)

MIRA Insider Trading Activity - Frequently Asked Questions

The list of insiders at MIRA Pharmaceuticals includes Brian Patrick Mcnulty, Erez Aminov, and George Cappy. Learn more on insiders at MIRA.

6.65% of MIRA Pharmaceuticals stock is owned by insiders. Learn more on MIRA's insider holdings.

The following insiders have purchased MIRA shares in the last 24 months: Erez Aminov ($8,178.00), and George Cappy ($1,933,526.00).

Insiders have purchased a total of 284,918 MIRA shares in the last 24 months for a total of $1,941,704.00 bought.

The following insiders have sold MIRA shares in the last 24 months: Brian Patrick Mcnulty ($618,577.14), and Erez Aminov ($77,019.90).

Insiders have sold a total of 250,089 MIRA Pharmaceuticals shares in the last 24 months for a total of $695,597.04 sold.

MIRA Pharmaceuticals Key Executives

  • Mr. Erez Aminov (Age 45)
    CEO & Chairman
    Compensation: $337.05k
    1 recent trades
  • Ms. Michelle Yanez M.B.A. (Age 51)
    CFO, Secretary & Treasurer
    Compensation: $338.77k
  • Dr. Itzchak Angel Ph.D.
    Chief Scientific Advisor


This page (NASDAQ:MIRA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners